📰 Phase News
Page 1486 - Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.
February 26, 2021
Clouds will be clearing tonight with lows falling to near 30° and winds will be shifting out of the east and eventually the south. This southerly wind will help boost temperatures back to the 50s for Friday afternoon. Skies will start mostly sunny, but extra clouds will move in for the afternoon and evening and these clouds could produce a few rain showers. These showers will have to battle some dry air near the surface, and that will limit the rain to light quick moving showers. Generally r...
February 25, 2021
(2) DJ Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant Foxconn GyroGear Ltd. Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant Foxconn 25-Feb-2021 / 15:25 GMT/BST =---------------------------------------------------------------------------------------------------------------------- Medtech Startup GyroGear raises USUSD4.3m in Phase One of Seed Round led by Taiwan Manufacturing Giant ...
February 25, 2021
LONDON (dpa-AFX) - GlaxoSmithKline (GSK.L, GSK) said that a phase 2 clinical trial of its otilimab in hospitalized COVID-19 patients did not reach statistical significance. However, a pre-planned
February 24, 2021
TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK) said Wednesday that the first subject was dosed in its Phase 1/2 immunogenicity and safety study of Novavax' COVID-19 vaccine candidate
February 24, 2021
Theralase Technologies Inc.: Theralase Launches Fifth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study Theralase" or the " TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that University of Wisconsin Health-Madison (" UWH") has receiv...
February 24, 2021
Datuk Seri Aminuddin Harun. -filepic SEREMBAN: All 37 government health clinics in Negri Sembilan will be turned into vaccination centres under phase one of the National Covid-19 Immunisation Programme, says Mentri Besar Datuk Seri Aminuddin Harun. He added the frontliners will be the first to be given the vaccines beginning Thursday (Feb 25). "The frontliners wil start getting their jabs first, as they are most exposed to the virus. "It is my hope that they will have no qualms taking the vacci...
February 24, 2021
Dec 11, 2013 04:24 PM EST The Food and Drug Administration announced Wednesday that it would begin phasing antibiotics out of animal feed designed to help animals grow bigger on smaller portions, as well as phase in oversight of the remaining uses of such drugs. The shift centers on asking those pharmaceutical companies that produce antibiotics to change the products labeling as to limit their use for medical purposes. "What is voluntary is only the participation of animal pharmaceutical compan...
February 24, 2021
Cerrado Gold Inc.: Cerrado Gold Reports True Thickness of 42 Metres at 1.82 g/t Au and 14 Metres at 5.98 g/t Au and 2 Metres at 37.85 g/t Au from Its Ongoing Phase I Drill Program at Its Monte Do Carmo Project in Brazil Cerrado to start trading Thursday February 25 th Toronto, Ontario--(Newsfile Corp. - February 24, 2021) - Cerrado Gold Inc. (TSXV: CERT) ("Cerrado" or the "Company") is very pleased to announce additional drill results from a further six drill holes from its ongoing 17,000-met...
February 23, 2021
Equity Metals Corporation: Equity Metals Commences Phase III Drilling at the Silver Queen Property, B.C. Equity Metals Corporation (TSXV: EQTY) (OTCQB: EQMEF) ("Equity") reports today that the previously announced Phase III 4,000-metre drill program is underway on the Silver Queen Property, B.C., with the program focusing on the southeastern portion of the high-grade, gold-enriched No. 3 and NG-3 veins. Assay results from eight core holes drilled during Phase II, completed in December 2020 as...
February 23, 2021
Altasciences Performs Phase I Studies for FDA Approval of Vibegron Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is a beta-3 adrenergic receptor (ß3) agonist, for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency in adults. The approval was announced by Urovant Sciences on December 23, 2020. " We take tremendous pride in co...